{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:51:53Z","timestamp":1790718713027,"version":"4.1.0"},"reference-count":60,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T00:00:00Z","timestamp":1686528000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006190","name":"Research and Development","doi-asserted-by":"publisher","award":["2016YFC1202903"],"award-info":[{"award-number":["2016YFC1202903"]}],"id":[{"id":"10.13039\/100006190","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>Tick-borne encephalitis virus (TBEV) belonging to arboviruses is a major member of zoonotic pathogens. TBEV infection causes severe human encephalitis without specific antiviral drugs. Due to its use of antiviral drug against a wide range of viruses, we investigated antiviral effect of ribavirin against TBEV in susceptible human cell lines A549 and SH-SY5Y. Ribavirin displayed minor cytotoxicity on multiple cell lines. Ribavirin obviously impaired TBEV replication and protected the infected cells from cytopathic effect. Importantly, ribavirin markedly inhibited TBEV propagation, as evidenced by impairment of TBEV production and viral RNA replication. Treatment with ribavirin (co-treatment and post-treatment) led to a dose-dependent reduction in TBEV titers as well as the viral RNA levels. Antiviral protein myxovirus resistance A mRNA expression was significantly up-regulated and signal transducer and activator of transcription 3 was activated in TBEV-infected A549 cells upon the ribavirin treatment. Induction of inflammatory cytokine tumor necrosis factor alpha by TBEV was decreased in A549 cells with the treatment of ribavirin, whereas interleukin 1 beta release appeared to be unaffected. These results suggest that ribavirin might represent a promising safe and effective antiviral drug against TBEV.<\/jats:p>","DOI":"10.3389\/fmicb.2023.1182798","type":"journal-article","created":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T04:22:03Z","timestamp":1686543723000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Inhibition of tick-borne encephalitis virus in cell cultures by ribavirin"],"prefix":"10.3389","volume":"14","author":[{"given":"Wan-Da","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Lin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-Ran","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-Wen","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan-Juan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,6,12]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"e2830","DOI":"10.21769\/BioProtoc.2830","article-title":"Time-of-addition and temperature-shift assays to determine particular step(s) in the viral life cycle that is blocked by antiviral substance(s)","volume":"8","author":"Aoki-Utsubo","year":"2018","journal-title":"Bio. Protoc."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1093\/jac\/dkr136","article-title":"Ribavirin for patients with Crimean-Congo haemorrhagic fever: a systematic review and meta-analysis","volume":"66","author":"Ascioglu","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1046\/j.1365-2249.2003.02050.x","article-title":"Changes in immune parameters and their correction in human cases of tick-borne encephalitis","volume":"131","author":"Atrasheuskaya","year":"2003","journal-title":"Clin. Exp. Immunol."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.coviro.2014.04.011","article-title":"Ribavirin: a drug active against many viruses with multiple effects on virus replication and propagation. Molecular basis of ribavirin resistance","volume":"8","author":"Beaucourt","year":"2014","journal-title":"Curr. Opin. Virol."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.3389\/fimmu.2018.02174","article-title":"Cell-mediated immune responses and immunopathogenesis of human tick-borne encephalitis virus-infection","volume":"9","author":"Blom","year":"2018","journal-title":"Front. Immunol."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.3109\/10428194.2010.496506","article-title":"Ribavirin as an anti-cancer therapy: acute myeloid leukemia and beyond?","volume":"51","author":"Borden","year":"2010","journal-title":"Leuk. Lymphoma"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/jac\/14.suppl_a.27","article-title":"In-vivo activity of antivirals against exotic RNA viral infections","volume":"14","author":"Canonico","year":"1984","journal-title":"J. Antimicrob. Chemother."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1158\/1535-7163","article-title":"The use of ribavirin as an anticancer therapeutic: will it go viral?","volume":"18","author":"Casaos","year":"2019","journal-title":"Mol. Cancer Ther."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"3008","DOI":"10.1099\/jgv.0.000967","article-title":"Enterovirus 71 antagonizes the antiviral activity of host STAT3 and IL-6R with partial dependence on virus-induced miR-124","volume":"98","author":"Chang","year":"2017","journal-title":"J. Gen. Virol."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"557","DOI":"10.2217\/fvl-2018-0033","article-title":"STAT3 roles in viral infection: antiviral or proviral?","volume":"13","author":"Chang","year":"2018","journal-title":"Future Virol."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"15931","DOI":"10.1038\/s41598-017-16130-w","article-title":"Broad-spectrum antiviral agents: secreted phospholipase A2 targets viral envelope lipid bilayers derived from the endoplasmic reticulum membrane","volume":"7","author":"Chen","year":"2017","journal-title":"Sci. Rep."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.3201\/eid2808.211787","article-title":"Lack of evidence for ribavirin treatment of Lassa fever in systematic review of published and unpublished studies","volume":"28","author":"Cheng","year":"2022","journal-title":"Emerg. Infect. Dis."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/s0166-3542(02)00185-7","article-title":"Interferon, ribavirin, 6-azauridine and glycyrrhizin: antiviral compounds active against pathogenic flaviviruses","volume":"58","author":"Crance","year":"2003","journal-title":"Antivir. Res."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.phrs.2018.02.030","article-title":"Dosing ribavirin in hepatitis E-infected solid organ transplant recipients","volume":"130","author":"De Winter","year":"2018","journal-title":"Pharmacol. Res."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.3390\/v14071381","article-title":"High-throughput screening of FDA-approved drug library reveals ixazomib is a broad-spectrum antiviral agent against arboviruses","volume":"14","author":"Ding","year":"2022","journal-title":"Viruses"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.antiviral.2016.07.018","article-title":"Structure-activity relationships of nucleoside analogues for inhibition of tick-borne encephalitis virus","volume":"133","author":"Eyer","year":"2016","journal-title":"Antivir. Res."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.antiviral.2017.03.012","article-title":"Antiviral activity of the adenosine analogue BCX4430 against West Nile virus and tick-borne flaviviruses","volume":"142","author":"Eyer","year":"2017","journal-title":"Antivir. Res."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"271","DOI":"10.4049\/jimmunol.2101216","article-title":"Identification of cell types and transcriptome landscapes of porcine epidemic diarrhea virus-infected porcine small intestine using single-cell RNA sequencing","volume":"210","author":"Fan","year":"2023","journal-title":"J. Immunol."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"e624","DOI":"10.1371\/journal.pntd.0000624","article-title":"The neglected arboviral infections in mainland China","volume":"4","author":"Gao","year":"2010","journal-title":"PLoS Negl. Trop. Dis."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1089\/jir.2004.24.659","article-title":"MxA and PKR expression in chronic hepatitis C","volume":"24","author":"Giannelli","year":"2004","journal-title":"J. Interf. Cytokine Res."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1177\/1060028015597449","article-title":"Oral ribavirin for the treatment of noninfluenza respiratory viral infections: a systematic review","volume":"49","author":"Gross","year":"2015","journal-title":"Ann. Pharmacother."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1089\/jir.2010.0076","article-title":"Human MxA protein: an interferon-induced dynamin-like GTPase with broad antiviral activity","volume":"31","author":"Haller","year":"2011","journal-title":"J. Interf. Cytokine Res."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"e1009636","DOI":"10.1371\/journal.ppat.1009636","article-title":"Antagonism of STAT3 signalling by Ebola virus","volume":"17","author":"Harrison","year":"2021","journal-title":"PLoS Pathog."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"S750","DOI":"10.1093\/clinids\/11.supplement_4.s750","article-title":"Prospects for treatment of viral hemorrhagic fevers with ribavirin, a broad-spectrum antiviral drug","volume":"11","author":"Huggins","year":"1989","journal-title":"Rev. Infect. Dis."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1128\/AAC.26.4.476","article-title":"Synergistic antiviral effects of ribavirin and the C-nucleoside analogs tiazofurin and selenazofurin against togaviruses, bunyaviruses, and arenaviruses","volume":"26","author":"Huggins","year":"1984","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"14","DOI":"10.4103\/0972-9062.308794","article-title":"Geographic distribution of tick-borne encephalitis virus complex","volume":"57","author":"Im","year":"2020","journal-title":"J. Vector Borne Dis."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"CD012713","DOI":"10.1002\/14651858.CD012713.pub2","article-title":"Ribavirin for treating Crimean Congo haemorrhagic fever","volume":"6","author":"Johnson","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1086\/315847","article-title":"Ribavirin inhibits West Nile virus replication and cytopathic effect in neural cells","volume":"182","author":"Jordan","year":"2000","journal-title":"J. Infect. Dis."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"575","DOI":"10.3851\/IMP2524","article-title":"Andes-virus-induced cytokine storm is partially suppressed by ribavirin","volume":"18","author":"Khaiboullina","year":"2013","journal-title":"Antivir. Ther."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.3390\/molecules24061129","article-title":"Antiviral activity of uridine derivatives of 2-deoxy sugars against tick-borne encephalitis virus","volume":"24","author":"Krol","year":"2019","journal-title":"Molecules"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"139","DOI":"10.18821\/0507-4088-2016-61-3","article-title":"Antiviral activity of various drugs with different mechanisms of action in patients with experimental tick-borne encephalitis","volume":"61","author":"Krylova","year":"2016","journal-title":"Vopr. Virusol."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s10517-018-4099-5","article-title":"Mechanisms of antiviral activity of the polyphenol complex from seagrass of the Zosteraceae family against tick-borne encephalitis virus","volume":"165","author":"Krylova","year":"2018","journal-title":"Bull. Exp. Biol. Med."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1002\/jmv.22033","article-title":"Microarray hybridization for assessment of the genetic stability of chimeric West Nile\/dengue 4 virus","volume":"83","author":"Laassri","year":"2011","journal-title":"J. Med. Virol."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"28020","DOI":"10.1002\/jmv.28020","article-title":"CXCL1 confers a survival advantage in Kaposi's sarcoma-associated herpesvirus-infected human endothelial cells through STAT3 phosphorylation","volume":"95","author":"Lee","year":"2023","journal-title":"J. Med. Virol."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"e0205294","DOI":"10.1371\/journal.pone.0205294","article-title":"Evaluation of antivirals against tick-borne encephalitis virus in organotypic brain slices of rat cerebellum","volume":"13","author":"Lenz","year":"2018","journal-title":"PLoS One"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s10517-020-05003-4","article-title":"Molecular and genetic bases of inhibition of tick-borne encephalitis virus replication by eprosartan and ribavirin","volume":"170","author":"Leonova","year":"2020","journal-title":"Bull. Exp. Biol. Med."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/hep.21072","article-title":"Targeted delivery of ribavirin improves outcome of murine viral fulminant hepatitis via enhanced anti-viral activity","volume":"43","author":"Levy","year":"2006","journal-title":"Hepatology"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1007\/s00705-017-3291-7","article-title":"Ribavirin attenuates the respiratory immune responses to influenza viral infection in mice","volume":"162","author":"Liao","year":"2017","journal-title":"Arch. Virol."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.mib.2013.04.005","article-title":"An evolutionary perspective on the broad antiviral specificity of MxA","volume":"16","author":"Mitchell","year":"2013","journal-title":"Curr. Opin. Microbiol."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1099\/vir.0.055632-0","article-title":"Human metapneumovirus inhibits the IL-6-induced JAK\/STAT3 signalling cascade in airway epithelium","volume":"95","author":"Mitzel","year":"2014","journal-title":"J. Gen. Virol."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/0166-3542(96)89697-5","article-title":"Use of the yellow fever virus vaccine strain 17D for the study of strategies for the treatment of yellow fever virus infections","volume":"30","author":"Neyts","year":"1996","journal-title":"Antivir. Res."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"3487","DOI":"10.4049\/jimmunol.160.7.3487","article-title":"Ribavirin inhibits viral-induced macrophage production of TNF, IL-1, the procoagulant fgl2 prothrombinase and preserves Th1 cytokine production but inhibits Th2 cytokine response","volume":"160","author":"Ning","year":"1998","journal-title":"J. Immunol."},{"key":"ref43","doi-asserted-by":"publisher","first-page":"e2112725119","DOI":"10.1073\/pnas.2112725119","article-title":"Targeting ectromelia virus and TNF\/NF-\u03baB or STAT3 signaling for effective treatment of viral pneumonia","volume":"119","author":"Pandey","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"ref44","doi-asserted-by":"publisher","first-page":"350","DOI":"10.3390\/v10070350","article-title":"Tick-borne encephalitis virus: a structural view","volume":"10","author":"Pulkkinen","year":"2018","journal-title":"Viruses"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.antiviral.2015.10.005","article-title":"Inhibition of dengue virus production and cytokine\/chemokine expression by ribavirin and compound a","volume":"124","author":"Rattanaburee","year":"2015","journal-title":"Antivir. Res."},{"key":"ref46","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.jhep.2008.11.006","article-title":"Ribavirin: current role in the optimal clinical management of chronic hepatitis C","volume":"50","author":"Reddy","year":"2009","journal-title":"J. Hepatol."},{"key":"ref47","doi-asserted-by":"publisher","first-page":"e1006839","DOI":"10.1371\/journal.ppat.1006839","article-title":"Viral manipulation of STAT3: evade, exploit, and injure","volume":"14","author":"Roca Suarez","year":"2018","journal-title":"PLoS Pathog."},{"key":"ref48","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/s12539-009-0039-4","article-title":"Structural modeling of the NS3 helicase of tick-borne encephalitis virus and their virtual screening of potent drugs using molecular docking","volume":"1","author":"Singh","year":"2009","journal-title":"Interdiscip. Sci."},{"key":"ref49","doi-asserted-by":"publisher","first-page":"40","DOI":"10.17116\/hirurgia20190715","article-title":"The efficacy of anti-viral therapy and serotherapy of tick-borne encephalitis in children","volume":"119","author":"Skripchenko","year":"2019","journal-title":"Zh. Nevrol. Psikhiatr. Im. S S Korsakova"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"e27866","DOI":"10.1371\/journal.pone.0027866","article-title":"Ribavirin enhances IFN-\u03b1 signalling and MxA expression: a novel immune modulation mechanism during treatment of HCV","volume":"6","author":"Stevenson","year":"2011","journal-title":"PLoS One"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"4918","DOI":"10.1002\/jmv.27891","article-title":"Identification of clinical candidates against West Nile virus by activity screening in vitro and effect evaluation in vivo","volume":"94","author":"Tang","year":"2022","journal-title":"J. Med. Virol."},{"key":"ref52","doi-asserted-by":"publisher","first-page":"4037","DOI":"10.1007\/s12325-022-02256-5","article-title":"Ribavirin for treatment of subjects with respiratory syncytial virus-related infection: a systematic review and meta-analysis","volume":"39","author":"Tejada","year":"2022","journal-title":"Adv. Ther."},{"key":"ref53","doi-asserted-by":"publisher","first-page":"e1000721","DOI":"10.1371\/journal.ppat.1000721","article-title":"Marburg virus evades interferon responses by a mechanism distinct from ebola virus","volume":"6","author":"Valmas","year":"2010","journal-title":"PLoS Pathog."},{"key":"ref54","doi-asserted-by":"publisher","first-page":"3037","DOI":"10.1038\/onc.2016.457","article-title":"Use of an anti-viral drug, ribavirin, as an anti-glioblastoma therapeutic","volume":"36","author":"Volpin","year":"2017","journal-title":"Oncogene"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.antiviral.2017.03.006","article-title":"IL-22 suppresses the infection of porcine enteric coronaviruses and rotavirus by activating STAT3 signal pathway","volume":"142","author":"Xue","year":"2017","journal-title":"Antivir. Res."},{"key":"ref56","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/j.1462-5822.2007.01027.x","article-title":"West Nile virus capsid protein induces p53-mediated apoptosis via the sequestration of HDM2 to the nucleolus","volume":"10","author":"Yang","year":"2008","journal-title":"Cell. Microbiol."},{"key":"ref57","doi-asserted-by":"publisher","first-page":"29035","DOI":"10.1073\/pnas.2016691117","article-title":"The NF-\u03baB\/leukemia inhibitory factor\/STAT3 signaling pathway in antibody-mediated suppression of Sindbis virus replication in neurons","volume":"117","author":"Yeh","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"ref58","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1292\/jvms.18-0373","article-title":"Epidemiology and pathological mechanisms of tick-borne encephalitis","volume":"81","author":"Yoshii","year":"2019","journal-title":"J. Vet. Med. Sci."},{"key":"ref59","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.virusres.2013.10.012","article-title":"Tick-borne encephalitis virus triggers inositol-requiring enzyme 1 (IRE1) and transcription factor 6 (ATF6) pathways of unfolded protein response","volume":"178","author":"Yu","year":"2013","journal-title":"Virus Res."},{"key":"ref60","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.antiviral.2012.09.002","article-title":"Interference with ERK and STAT signaling pathways and inhibition of hepatitis C virus replication by ribavirin","volume":"96","author":"Zhao","year":"2012","journal-title":"Antivir. Res."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2023.1182798\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T04:22:07Z","timestamp":1686543727000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2023.1182798\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,12]]},"references-count":60,"alternative-id":["10.3389\/fmicb.2023.1182798"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2023.1182798","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,12]]},"article-number":"1182798"}}